# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division A: Confirmed case

Extent: E+W+S+N.I.

Pleocytosis in cerebrospinal fluid, AND
Evidence of intrathecal production of Lyme borreliosis antibodies, OR
Borrelia burdgorferi s.l. isolation, OR
nucleic acid detection in cerebrospinal fluid
OR
Detection of IgG Lyme borreliosis antibodies in blood specimen only for children (age under 18) with facial palsy or other cranial neuritis and a recent (< 2 months) history of erythema migrans

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.25/division/2/division/A (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.25/division-2/division-A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.